Finance

Lists
HCAT:NASDAQ
Health Catalyst Inc
$1.69
-1.17%
(-0.020) 1D
$1.64
-2.96% (-0.050)
After hours
Closed: Sep 4, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HCAT...
Open
$1.68
High
$1.71
Low
$1.67
Mkt. cap
127.18M
Avg. vol.
791.41K
Volume
401.89K
52-wk high
$3.62
52-wk low
$0.96
EPS
-$3.68
Beta
1.53
Shares outstanding
75.26M
No. of employees
1K
Open
$1.68
High
$1.71
Low
$1.67
Mkt. cap
127.18M
Avg. vol.
791.41K
Volume
401.89K
52-wk high
$3.62
52-wk low
$0.96
EPS
-$3.68
Beta
1.53
Shares outstanding
75.26M
No. of employees
1K
News stories
From web sources and news partners
About Health Catalyst Inc
CEODan Burton
Employees1.2K
Founded2008
HeadquartersSouth Jordan, Utah, United States
SectorHealth care
Websitehealthcatalyst.com
Analyst ratings
Based on 6 analysts giving stock ratings to HCAT in the past 3 months
Hold
Buy
1
Hold
5
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for HCAT in the last 3 months.
Highest
Current $1.69
$2.00 (+18.34%)
Average
$1.83 (+8.28%)
Lowest
$1.50 (-11.24%)
Analyst
Recommendation
Action
Price target
Projected
Date
Richard Close
Canaccord Genuity
Hold
Downgraded
$1.80
+6.5%
08/21/2026
David Larsen
BTIG
Hold
Reiterated
-
-
08/19/2026
Stan Berenshteyn
Wells Fargo
Hold
Reiterated
$1.50
-11.2%
08/13/2026
Daniel Grosslight
Citi
Hold
Reiterated
$2.00
+18.3%
08/10/2026
David Grossman
Stifel Nicolaus
Hold
Maintained
$2.00
+18.3%
08/07/2026
Ryan Daniels
William Blair
Buy
Maintained
-
-
08/06/2026
Jeffrey Garro
Stephens
Hold
Maintained
$1.75
+3.6%
05/12/2026
Jessica Tassan
Piper Sandler
Hold
Reiterated
$2.00
+18.3%
05/12/2026
Sarah James
Cantor Fitzgerald
Hold
Maintained
$3.00
+77.5%
05/08/2026
Elizabeth Anderson CFA
Evercore ISI
Hold
Maintained
$3.00
+77.5%
03/30/2026
Unknown Analyst
Stephens
Hold
Maintained
$2.00
+18.3%
03/13/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.04 / $0.03
+29.87%beat
Revenue / Est. (USD)
70.49M / 69.28M
+1.75%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
76.32M
74.68M
70.76M
70.49M
Cost of goods sold
37.39M
35.29M
34.98M
35.07M
Cost of revenue
37.39M
35.29M
34.98M
35.07M
Research and development expenses
10.91M
9.87M
9.67M
9.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23.07M
19.85M
20.73M
18.67M
Operating expense
46.59M
42.60M
42.52M
39.19M
Total operating expenses
83.98M
77.88M
77.50M
74.26M
Operating income
-7.65M
-3.20M
-6.75M
-3.77M
Other non operating income
-180.00K
41.00K
-191.00K
-21.00K
EBT including unusual items
-22.19M
-90.65M
-110.61M
-40.22M
EBT excluding unusual items
-12.33M
-7.77M
-10.88M
-7.51M
Income tax expense
41.00K
379.00K
414.00K
315.00K
Effective tax rate
-0.18%
-0.42%
-0.37%
-0.78%
Other operating expenses
-
-
-
-
Net income
-22.23M
-91.02M
-111.03M
-40.54M
Net profit margin
-29.12%
-121.89%
-156.91%
-57.51%
Earnings per share
0.06
0.08
0.02
0.04
Interest and investment income
1.14M
909.00K
798.00K
924.00K
Interest expense
-5.64M
-5.52M
-4.74M
-4.64M
Net interest expenses
-4.50M
-4.61M
-3.94M
-3.72M
Depreciation and amortization charges
12.61M
12.88M
12.12M
10.98M
EBITDA
1.76M
6.28M
1.87M
4.01M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps